Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 151 for your search:
Cancer Type/Condition:
Neuroblastoma
Trial Type:
All
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma
Phase:
Phase IV, Phase III
Type:
Treatment
Status:
Active
Age:
21 and under
Sponsor:
Other
Protocol IDs:
GPOH-NB2004
, EU-20661, NCT00410631
2.
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
Phase:
Phase IV
Type:
Supportive care
Status:
Active
Age:
20 to 75
Sponsor:
Other
Protocol IDs:
UCSD 060340
, ESRC 054, NCT00365261
3.
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload
Phase:
Phase IV
Type:
Diagnostic, Supportive care
Status:
Active
Age:
16 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CICL670AAU01
, NCT00673608
4.
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Phase:
Phase III, Phase II
Type:
Supportive care, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
Levosta-CBF-02/04
, NCT00215007
5.
Phase II/III Study of Disease-Specific High-Dose Conditioning Regimens Followed by Autologous Stem Cell Transplantation (Single or Tandem) in Patients With Hematologic Malignancies or Solid Tumors
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
4 and over
Sponsor:
NCI
Protocol IDs:
RPCI-I-72806
, I 72806, NCT00536601
6.
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
Phase:
Phase III, Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2006-0374
, NCT00539500
7.
Phase III Randomized Study of Adjuvant Isotretinoin With or Without Monoclonal Antibody Ch14.18, Interleukin-2, and Sargramostim (GM-CSF) in Patients With Neuroblastoma Who Have Completed Myeloablative Therapy and Autologous Stem Cell Transplantation (Arm I Closed to Accrual as of 4/16/2009)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
30 and under at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-ANBL0032
, ANBL0032, COG-P9842, NCT00026312
8.
Phase III Randomized Study of Induction Chemotherapy With or Without Filgrastim (G-CSF) Followed By Surgery, Myeloablative Therapy, and Radiotherapy With Isotretinoin With or Without Monoclonal Antibody Ch14.18 in Patients With High-Risk Neuroblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to 20 at diagnosis
Sponsor:
Other
Protocol IDs:
SIOP-EUROPE-HR-NBL-1
, ESIOP, EU-20148, NCT00030719
9.
Phase III Randomized Study of Cyclophosphamide and Prednisone With or Without Immune Globulin in Pediatric Patients With Neuroblastoma-Associated Opsoclonus-Myoclonus-Ataxia Syndrome
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
8 and under
Sponsor:
NCI
Protocol IDs:
COG-ANBL00P3
, ANBL00P3, NCT00033293
10.
Phase III Randomized Study of a Therapeutic Music Video Intervention Versus Listening and Discussing Books on Tape for Increased Resilience and Quality of Life of Adolescents and Young Adults Undergoing Myeloablative Autologous or Allogeneic Transplantation for Cancer
Phase:
Phase III
Type:
Educational/Counseling/Training
Status:
Active
Age:
11 to 24
Sponsor:
NCI, NINR
Protocol IDs:
COG-ANUR0631
, NCT00305851
11.
Phase III Randomized Pilot Study of Prophylactic Moxifloxacin Hydrochloride in Preventing Bacterial Infections During the Post-Engraftment Phase in Patients Who Have Undergone Allogeneic Stem Cell Transplantation
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
OHSU-TPI-02027-L
, NCT00324324
12.
A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients
Phase:
Phase III
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 to 80
Sponsor:
Other
Protocol IDs:
55/05
, ALLG SC01, NHMRC Project Grant 331305, NCT00163722
13.
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
12 to 65
Sponsor:
Other
Protocol IDs:
PROGAST
, NCT00180089
14.
Phase III Study of Response- and Biology-Based Combination Chemotherapy and Surgery With or Without Isotretinoin in Young Patients With Intermediate-Risk Neuroblastoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
12 and under
Sponsor:
NCI
Protocol IDs:
COG-ANBL0531
, ANBL0531, NCT00499616
15.
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
Not specified
Sponsor:
NHLBI
Protocol IDs:
557
, U01 HL072305-01, HL072268, HL072291, HL072196, HL072248, HL072191, HL072305, HL072028, HL072072, HL072355, HL072283, HL072346, HL072331, HL072290, NCT00627393
16.
The Effectiveness of the Neutropenic Diet in Pediatric Cancer Patients
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
1 to 21
Sponsor:
Other
Protocol IDs:
06-08-367
, NCT00726934
17.
Phase III Randomized Study of a Web-Based Hematopoietic Stem Cell Transplantation Comprehensive Health Enhancement Support System (HSCT-CHESS) Versus Usual Care in Recipient Families With a Pediatric Patient Undergoing HSCT
Phase:
Phase III
Type:
Educational/Counseling/Training, Natural history/Epidemiology
Status:
Active
Age:
5 to 18
Sponsor:
NCI
Protocol IDs:
TUFTS-8338
, #8338, WCCC-—2007-1357, CHW-07237, CHW-GC-580, DFCI-08-106, CHNMC-08009, CCHMC-0002988, FHCRC-2210, NCT00782145
18.
Phase III Randomized Study of a Psychoeducation, Paced Respiration, and Relaxation Intervention for Caregivers of Patients Undergoing Bone Marrow Transplantation
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Educational/Counseling/Training, Supportive care
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UCHSC-080303
, 08-0303, NCT00833898
19.
Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
12 to 26
Sponsor:
Other
Protocol IDs:
RCH CA27091
, NCT00964210
20.
Phase III Study of Monoclonal Antibody Ch14.18 in Combination With Sargramostim, Aldesleukin, and Isotretinoin Following Myeloablative Therapy in Patients With High-Risk Neuroblastoma
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI
Protocol IDs:
COG-ANBL0931
, ANBL0931, NCT01041638
21.
Phase I/II Study of Donor Lymphocyte Infusion in Patients With Persistent, Relapsed, or Progressing Malignancy After Nonmyeloablative Allogeneic Transplantation
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI
Protocol IDs:
FHCRC-1803.00
, 5606, NCT00068718
22.
Phase I/II Study of Pentostatin and Donor Lymphocyte Infusion in Preventing Graft Rejection in Cancer Patients With Low or Falling Donor T-Cell Chimerism After Nonmyeloablative Allogeneic Stem Cell Transplantation
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
Under 75
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
FHCRC-1825.00
, 5605, SUPERGEN-FHCRC-1825.00, NCT00096161
23.
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and under
Sponsor:
Other
Protocol IDs:
ECP RIT
, NCT00179790
24.
Rituximab for Prevention of Chronic GVHD
Phase:
Phase II, Phase I
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
05-377
, NCT00379587
25.
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
Phase:
Phase II, Phase I
Type:
Supportive care, Treatment
Status:
Approved-not yet active
Age:
18 to 55
Sponsor:
Other
Protocol IDs:
ApoCell-I-IIa
, NCT00524784
Select All on Page
1
Help with Results
